Risk factors for cardiovascular disease in patients with non-alcoholic fatty liver disease with polymorbidity

Risk factors for cardiovascular disease in patients with non-alcoholic fatty liver disease with polymorbidity

Aim. To study the associations of the frequency and values of parameters of the main risk factors (RF) of cardiovascular diseases (CVD) and the degree of transnosological polymorbidity (PM) in patients with nonalcoholic fatty liver disease (NAFLD).Material and methods. The analysis of 3667 medical r...

Full description

Bibliographic Details
Main Authors:	E. V. Sevostyanova, Yu. A. Nikolaev, I. M. Mitrofanov, V. Ya. Polyakov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2019-11-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	неалкогольная жировая болезнь печени факторы риска сердечно-сосудистые заболевания полиморбидность гендерные различия
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1220

Similar Items

How to avoid statin hepatotoxicity in patients with obesity and liver disease? Focus on the combination of ursodeoxycholic acid and atorvastatin
by: O. N. Korneeva, et al.
Published: (2012-12-01)

STATIN SAFETY REVISITED DATA
by: O. M. Drapkina
Published: (2015-09-01)

The role of non-alcoholic fatty liver disease in the formation of atherosclerotic vascular lesions in patients with abdominal obesity
by: N. L. Denisov, et al.
Published: (2018-08-01)

Relationship of lipid metabolism disorders with the development of fatal and non-fatal cardiovascular events in residents of the Chui region of the Kyrgyz Republic of varying sex and ethnicity
by: A. G. Polupanov, et al.
Published: (2022-03-01)

КЛИНИКО-ЛАБОРАТОРНЫЕ ОСОБЕННОСТИ У МОЛОДЫХ МУЖЧИН НА ФОНЕ НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНИ ПЕЧЕНИ
by: София Васильевна Яковлева, et al.
Published: (2022-11-01)

Assessment of the Functional Status of the Small Intestine in Patients with Non-Alcoholic Fatty Liver Disease
by: Ya. M. Vakhrushev, et al.
Published: (2020-12-01)

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)

A NEW APPROACH TO THE DIFFERENTIAL DIAGNOSIS OF NON-ALCOHOLIC AND ALCOHOLIC LIVER DISEASE
by: Ольга Александровна Морозова, et al.
Published: (2022-08-01)

Prevalence of non-alcoholic fatty liver disease among the working-age population: associations with socio-demographic indicators and behavioral risk factors (ESSE RF-2 data)
by: S. E. Evstifeeva, et al.
Published: (2022-10-01)

НЕАЛКОГОЛЬНАЯ ЖИРОВАЯ ДЕГЕНЕРАЦИЯ ПЕЧЕНИ У ЛЮДЕЙ РАЗЛИЧНЫХ ВОЗРАСТНЫХ ГРУПП: СОВРЕМЕННЫЙ ВЗГЛЯД НА ПРОБЛЕМУ
by: Яна Вячеславовна Савченко, et al.
Published: (2022-04-01)

МОРФОЛОГИЧЕСКИЕ ИЗМЕНЕНИЯ ПЕЧЕНИ ПРИ ЖИРОВОЙ ДИСТРОФИИ РАЗЛИЧНОЙ ЭТИОЛОГИИ
by: Татьяна Викторовна Брус, et al.
Published: (2021-11-01)

Cardiovascular morbidity and risk factors of cardiovascular events in the Russian Federation
by: I. V. Samorodskaya
Published: (2005-06-01)

PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN NON-ORGANIZED POPULATION OF 25-64 YEAR OLDS IN TYUMEN REGION. RESULTS OF ESSE-RF STUDY IN TYUMEN REGION
by: A. Yu. Efanov, et al.
Published: (2016-08-01)

Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China
by: M. Ch. Semenistaya, et al.
Published: (2018-08-01)

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2016-08-01)

DYNAMICS OF THE PREVALENCE BY VISIT OF ARTERIAL HYPERTENSION, CORONARY HEART DISEASE AND COMPLICATIONS DURING 6 YEARS IN RURAL AREAS INHABITANTS
by: I. N. Denisov, et al.
Published: (2018-06-01)

Algorithm for assessing the total 10 years risk of death from cardiovascular diseases in women 25-64 years old in Tyumen (Tyumen risk scale)
by: G. S. Pushkarev, et al.
Published: (2021-09-01)

ANALYSIS OF PREVALENCE OF RISK FACTORS OF CARDIOVASCULAR DISEASES AMONG MEN MEDICAL WORKERS OF MAJOR CLINICAL HOSPITAL OF KRASNOYARSK CITY
by: Evgeny Valeryevich Derevyannich, et al.
Published: (2017-10-01)

Возможности применения адеметионина у пациентов с неалкогольной жировой болезнью печени
Published: (2016-12-01)

НЕАЛКОГОЛЬНАЯ ЖИРОВАЯ БОЛЕЗНЬ ПЕЧЕНИ: ОТ ТЕОРИИ К ПРАКТИКЕ
by: П. В. Селивёрстов
Published: (2015-02-01)

WHY CARDIOVASCULAR MORTALITY IN MOSCOW IS LOWER THAN IN OTHER REGIONS OF THE RUSSIAN FEDERATION?
by: N. V. Pogosova, et al.
Published: (2015-04-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
by: K. A. Andreev, et al.
Published: (2022-01-01)

Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study. Ten years later
by: S. A. Boytsov, et al.
Published: (2021-09-01)

MARKERS OF RISK FACTORS FOR CARDIOVASCULAR DISEASE
by: N. H. Bashirov
Published: (2020-09-01)

The Influence of Non-Alc oholic Fatty Liver Disease on Indicators of Arterial Stiffness and Risk of Cardiovascular Complications in Patients with Arterial Hypertension
by: M. E. Statsenko, et al.
Published: (2020-07-01)

ДВИГАТЕЛЬНАЯ ФУНКЦИЯ КИШЕЧНИКА У ПАЦИЕНТОВ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ
by: Юрий Павлович Успенский, et al.
Published: (2020-10-01)

Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

ЧАСТОТА ФАКТОРОВ РИСКА РАЗВИТИЯ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ СРЕДИ ВЗРОСЛОГО НАСЕЛЕНИЯ ТОМСКОЙ ОБЛАСТИ (ПО РЕЗУЛЬТАТАМ ДЕЯТЕЛЬНОСТИ ЦЕНТРА ЗДОРОВЬЯ)
by: Н. Е. Найденова, et al.
Published: (2015-06-01)

Заболевания сердечно сосудистой системы как причина смертности в Российской Федерации: пути решения проблемы
by: Дмитрий Олегович Иванов, et al.
Published: (2020-05-01)

Factors influencing cardiovascular mortality in Russian population
by: S. A. Shalnova, et al.
Published: (2005-02-01)

PLEYOTROPIC EFFECTS OF METFORMIN
by: L. Ju. Morgunov
Published: (2015-01-01)

СОВРЕМЕННОЕ ПРЕДСТАВЛЕНИЕ О НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНИ ПЕЧЕНИ
by: Татьяна Викторовна Брус, et al.
Published: (2020-08-01)

Why treat non-alcoholic fatty liver disease?
by: I. G. Pakhomova, et al.
Published: (2013-12-01)

Стеатоз поджелудочной железы как кластер метаболического синдрома
by: Юлия Александровна Фоминых, et al.
Published: (2022-05-01)

ОСОБЕННОСТИ РЕМОДЕЛИРОВАНИЯ МИОКАРДА У ПАЦИЕНТОВ С НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНЬЮ ПЕЧЕНИ
by: Светлана Владимировна Туркина, et al.
Published: (2022-11-01)

CARDIOVASCULAR RISK FACTORS AMONG INHABITANTS OF RURAL AREAS BY THE EPIDEMIOLOGICAL DATA: REVIEW ARTICLE
by: A. V. Kontsevaya, et al.
Published: (2016-12-01)

RISK FACTORS OF DAMAGE OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH PRIMARY OSTEOARTHRITIS WITH IDENTIFIED CORONARY ATHEROSCLEROSIS
by: S. M. Tsvinger, et al.
Published: (2018-12-01)

Evaluation of cardiovascular risk factors for medical workers of an urban multidisciplinary hospital
by: K. G. Tkachenko, et al.
Published: (2019-09-01)

Intercommunication of blood group with cardiovascular disease risk factors
by: N. L. Dochkina, et al.
Published: (2005-10-01)